These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9673511)

  • 1. [Thrombolytic treatment in acute myocardial infarction. Choice of preparations in Norwegian hospitals].
    Andreassen AK; Gullestad L; Endresen K
    Tidsskr Nor Laegeforen; 1998 Jun; 118(17):2630-1. PubMed ID: 9673511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Streptokinase treatment in Nordkapp].
    Bjøru H; Langfeldt E; Løvland A; Nordang B; Høybjør S
    Tidsskr Nor Laegeforen; 1998 Jun; 118(17):2632-3. PubMed ID: 9673512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary thrombolysis--clinical guidelines and public policy: results of an Ontario practitioner survey.
    Naylor CD; Hollenberg AA; Ugnat AM; Basinski A
    CMAJ; 1990 May; 142(10):1069-76. PubMed ID: 2110859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide survey of prescribing patterns for thrombolytic drugs in acute myocardial infarction.
    Grasela TH; Green JA
    Pharmacotherapy; 1990; 10(1):35-41. PubMed ID: 2107535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of late thrombolytic perfusion in acute myocardial infarct].
    Gulba DC
    Z Kardiol; 1993; 82 Suppl 2():183-5. PubMed ID: 8328200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial].
    Steffensen R; Sandøe E
    Ugeskr Laeger; 1991 Oct; 153(41):2880-3. PubMed ID: 1949301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of return to work after streptokinase-treated acute myocardial infarction].
    Christensen JH; Ravn L; Rasmussen SE; Sørensen HT
    Ugeskr Laeger; 1996 Nov; 158(46):6620-2. PubMed ID: 8966830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide variation in the use of thrombolytic therapy among junior doctors in south and central Scotland.
    Hood S; Birnie D; Curzio JL; Hillis WS
    Health Bull (Edinb); 1996 Mar; 54(2):131-9. PubMed ID: 8655300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy].
    Chernetsov VA
    Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombolytic therapy in acute myocardial infarction].
    Pedersen TR
    Tidsskr Nor Laegeforen; 1994 May; 114(14):1646-7. PubMed ID: 8079271
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.
    Naylor CD; Armstrong PW
    CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study].
    Nielsen JD; Stoltenberg M; Siemsen M; Juul A; Pedersen F; Madsen JK
    Ugeskr Laeger; 1990 Aug; 152(33):2368-70. PubMed ID: 2120830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy for myocardial infarction. Treatment introduced in northern Ontario.
    Hutten-Czapski P
    Can Fam Physician; 1993 May; 39():1071-4. PubMed ID: 8257484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.